Search the Newsreel

SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript

MacroGenics 2026: Revenue $32.83M, EPS $0.31— 10-Q Summary

MacroGenics reported strong Q2 2026 results with revenue of $32.83M and diluted EPS of $0.31, largely driven by a TZIELD milestone payment and increased ZYNYZ royalty income. The company achieved net income of $19.52M, a significant improvement from the prior year's loss, following the …

PTC Therapeutics Is Maintained at Overweight by Barclays

Barclays has reiterated its 'Overweight' rating on PTC Therapeutics (PTCT). The analyst firm maintained a price target of $70.00 for the company's stock. This indicates a positive outlook from Barclays regarding PTC Therapeutics' future performance.

Price-Driven Insight from (CPBI) for Rule-Based Strategy

This article provides a price-driven analysis of Central Plains Bancshares Inc. Com (NASDAQ: CPBI), indicating a near-term neutral sentiment amidst mid and long-term strength. It highlights compelling upside potential with no resistance levels above the current price and presents three institutional trading strategies tailored …

Nasdaq, S&P 500 Futures Edge Lower Ahead Of Fed Week, AI Earnings Test: Why POET, ATOM, OGN, QCOM, NTLA Are In Focus

Delek Logistics Partners, LP (DKL) Latest Stock News & Headlines

Qnity Electronics director Karin de Bondt buys $138,136 in stock

Karin De Bondt, a director at Qnity Electronics, acquired 1,000 shares of the company's common stock for $138,136 on August 11, 2026. This purchase increases her direct holdings to 6,647.2799 shares. The acquisition follows a significant surge in Qnity Electronics' stock price, though InvestingPro …

HLS Therapeutics Inc. (TSE:HLS) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

AVG Logistics files Q1FY27 unaudited results with exchanges

Cantor Fitzgerald Reaffirms Their Buy Rating on Kimball Electronics (KE)

Outlook Therapeutics (OTLK) CFO Lawrence Kenyon buys 101K shares plus 101K warrants

Outlook Therapeutics' CFO, Lawrence A. Kenyon, purchased 101,010 shares of common stock and 101,010 accompanying warrants in an underwritten public offering on August 14, 2026. The combined offering price was $0.99 per share and warrant, with the warrants immediately exercisable at $1.10 and expiring …

PennyMac Financial Services, Inc. Declares Quarterly Dividend of $0.30 (NYSE:PFSI)

PennyMac Financial Services, Inc. (NYSE:PFSI) has declared a quarterly dividend of $0.30 per share, payable on August 27th to shareholders of record on August 17th. This dividend represents an annualized payout of $1.20 and a 1.5% yield. The dividend appears sustainable, with an 8.0% …

5 Insightful Analyst Questions From Arrow Electronics’s Q2 Earnings Call

5 Insightful Analyst Questions From Arrow Electronics's Q2 Earnings Call Arrow Electronics' Q2 results outperformed Wall Street's expectations on both revenue and adjusted earnings, but the market reacted negatively. Management attributed the quarter's strong performance to broad-based demand, disciplined expense management, and operating leverage, …

Universal Electronics (UEIC) Q2 2026 Earnings Call Transcript

Protagonist Therapeutics (NASDAQ:PTGX) Screens as an Affordable Growth Opportunity

PACS Group (PACS) Is Down 8.3% After Raising 2026 Revenue Guidance And Holding Buybacks Steady

In early August 2026, PACS Group, Inc. reported second-quarter results showing revenue of US$1,428 million and net income of US$76.37 million, and raised its full-year 2026 revenue guidance to a range of US$5.75 billion to US$5.85 billion from US$5.65 billion to US$5.75 billion. Despite …

Prosperity Bancshares director Holmes sells $81,550 in stock By Investing.com

Ned S. Holmes, a director at Prosperity Bancshares Inc (NYSE:PB), recently sold common stock totaling $81,550 across various transactions on August 12, 2026. These sales occurred as the stock traded near its 52-week high, with shares sold directly, through a profit-sharing plan, and indirectly …

XORTX Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock

Edgewise Therapeutics CEO Kevin Koch sold $785,042 worth of company stock on August 12, 2026, primarily to cover tax obligations related to Restricted Stock Unit vesting. Despite the sales, Mr. Koch also acquired new shares through vesting and was granted additional RSUs and stock …

Walleye Capital LLC Buys Shares of 4,935 CSW Industrials, Inc. $CSW

Walleye Capital LLC initiated a new position in CSW Industrials, Inc. (NYSE:CSW) by purchasing 4,935 shares valued at approximately $1.37 million during the second quarter. Institutional investors collectively own 82.79% of the company, while recent analyst reports indicate a "Moderate Buy" consensus with an …

Walleye Capital LLC Takes $1.59 Million Position in PTC Therapeutics, Inc. $PTCT

Walleye Capital LLC has acquired a new position in PTC Therapeutics, Inc., purchasing 19,522 shares valued at approximately $1.59 million during the second quarter. Several other institutional investors also increased their holdings in the biopharmaceutical company, which has an average analyst rating of "Moderate …

Prosperity Bancshares director Holmes sells $81,550 in stock

Prosperity Bancshares director Ned S. Holmes recently sold $81,550 worth of common stock through direct, profit-sharing plan, and trust transactions. The sales occurred on August 12, 2026, with shares trading near their 52-week high. These sales follow the bank's merger with Stellar Bancorp and …

LENZ Therapeutics (NASDAQ:LENZ) Stock Rating Upgraded by Zacks Research

Walleye Capital LLC Acquires New Stake in Live Oak Bancshares, Inc. $LOB

Ritco Logistics Publishes Q1 FY 2026-27 Unaudited Results in Newspapers

Walleye Capital LLC Purchases New Shares in Kyverna Therapeutics, Inc. $KYTX

Walleye Capital LLC Purchases New Stake in Aquestive Therapeutics, Inc. $AQST

Walleye Capital LLC has acquired a new stake of 282,568 shares in Aquestive Therapeutics, Inc. (NASDAQ:AQST), valued at approximately $1.18 million. Institutional investors collectively hold 32.45% of the company's stock, while insider ownership stands at 6.81%. Despite a wider-than-expected quarterly loss, analysts maintain a …

Mineralys Therapeutics (NASDAQ:MLYS) Downgraded by Zacks Research to "Strong Sell"

Zacks Research downgraded Mineralys Therapeutics (NASDAQ:MLYS) to a "Strong Sell" rating, despite a mixed analyst sentiment with an average "Hold" rating and a $49.33 price target. The downgrade follows a significant earnings miss, with the company reporting a quarterly loss of $2.85 per share …

Zacks Research Downgrades Monopar Therapeutics (NASDAQ:MNPR) to Hold

Zacks Research downgraded Monopar Therapeutics (NASDAQ:MNPR) from a "strong-buy" to a "hold" rating, despite the broader analyst consensus remaining a "moderate buy" with an average price target of $117.42. The company's shares opened at $113.04, trading near their 12-month high, and it recently reported …

Ritco Logistics posts resilient Q1 FY27 results despite petrochemical headwinds

Oppenheimer Asset Management Inc. Acquires New Position in Verisk Analytics, Inc. $VRSK

Oppenheimer Asset Management Inc. has acquired a new position in Verisk Analytics, Inc. (NASDAQ:VRSK), purchasing 111,878 shares valued at approximately $20.085 million during the second quarter. The article also details other institutional investor activities, Verisk Analytics' recent financial performance, dividend announcement, and analyst ratings. …

Walleye Capital LLC Purchases Shares of 102,163 Rapport Therapeutics, Inc. $RAPP

Walleye Capital LLC has acquired a new position in Rapport Therapeutics, purchasing 102,163 shares valued at $4.26 million, representing 0.21% of the company. Despite the stock opening near its 52-week high, Rapport Therapeutics reported a quarterly loss of $1.19 per share, missing estimates. Analysts …

Laser Photonics Reports Second Quarter 2026 Financial Results

Laser Photonics Corporation reported its second-quarter 2026 financial results, showing a near doubling of net sales sequentially to $1.8 million and a return to positive gross margin at 8.4%. The company also highlighted significant advancements in its Laser Shield Anti-Drone System with U.S. government …

Walleye Capital LLC Acquires Shares of 179,992 Southern First Bancshares, Inc. $SFST

Walleye Capital LLC has acquired 179,992 shares of Southern First Bancshares, Inc. (NASDAQ:SFST) in the second quarter, valued at approximately $11.0 million, representing about 1.9% of the company. Institutional investors now collectively own 75% of SFST. Analysts maintain a positive outlook with a consensus …

Quantinno Capital Management LP Buys 24,878 Shares of Crinetics Pharmaceuticals, Inc. $CRNX

Quantinno Capital Management LP significantly increased its stake in Crinetics Pharmaceuticals, Inc. (CRNX) by 280.9% in Q1, acquiring an additional 24,878 shares to reach a total of 33,734 shares valued at $1.225 million. This comes as Crinetics Pharmaceuticals reported strong Q1 revenues of $25.12 …